tiprankstipranks
Trending News
More News >
Neurogene (NGNE)
NASDAQ:NGNE
US Market
Advertisement

Neurogene (NGNE) Technical Analysis

Compare
580 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
2Neutral
14Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Neurogene’s (NGNE) Moving Averages Convergence Divergence (MACD) indicator is -1.59, suggesting Neurogene is a Buy.
Neurogene’s (NGNE) 20-Day exponential moving average is 26.18, while Neurogene’s (NGNE) share price is $20.4, making it a Sell.
Neurogene’s (NGNE) 50-Day exponential moving average is 25.73, while Neurogene’s (NGNE) share price is $20.4, making it a Sell.

Neurogene (NGNE) Pivot Points

Nov 21, 2025, 05:17 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.02
19.79
20.39
21.15
21.75
22.52
23.12
Fibonacci
19.79
20.31
20.63
21.15
21.67
22.00
22.52
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neurogene (NGNE) Moving Averages

Nov 21, 2025, 05:17 PM
Period
Simple
Exponential
MA5
21.60Sell
22.13Sell
MA10
25.15Sell
24.25Sell
MA20
28.09Sell
26.18Sell
MA50
25.43Sell
25.73Sell
MA100
23.09Sell
23.75Sell
MA200
19.62Buy
21.38Sell
Neurogene’s (NGNE) 10-Day exponential moving average is 24.25, while Neurogene’s (NGNE) share price is $20.4, making it a Sell.
Neurogene’s (NGNE) 100-Day exponential moving average is 23.75, while Neurogene’s (NGNE) share price is $20.4, making it a Sell.
Neurogene’s (NGNE) stock price is $20.4 and Neurogene’s (NGNE) 50-day simple moving average is 25.43, creating a Sell signal.
Neurogene’s (NGNE) stock price is $20.4 and Neurogene’s (NGNE) 100-day simple moving average is 23.09, creating a Sell signal.
Neurogene’s (NGNE) stock price is $20.4 and Neurogene’s (NGNE) 200-day simple moving average is 19.62, creating a Buy signal.

Neurogene (NGNE) Technical Indicators

Nov 21, 2025, 05:17 PM
Name
Value
Implied Action
RSI (14)
34.77
Neutral
STOCH (9,6)
3.72
Buy
STOCHRSI (14)
3.15
Buy
MACD (12,26)
-1.59
Buy
ADX (14)
27.65
Neutral
Williams %R
-94.62
Buy
CCI (14)
-141.89
Buy
ATR (14)
3.06
-
Ultimate Oscillator
26.44
Sell
ROC
-40.46
Sell
Neurogene’s (NGNE) Relative Strength Index (RSI) is 34.77, creating a Neutral signal.
Neurogene’s (NGNE) Trend Strength Indicator (ADX) is 27.65, creating a Neutral signal.
Neurogene’s (NGNE) Commodity Channel Index (CCI) is -141.89, creating a Buy signal.
Neurogene’s (NGNE) Price Rate of Change (ROC) is -40.46, creating a Sell signal.

FAQ

Is NGNE a Buy, Hold, or Sell?
Based on NGNE’s technical indicators, NGNE is a Sell.
    What is NGNE’s RSI (14)?
    NGNE’s RSI (14) is 34.77, which suggests NGNE is a Neutral.
      What is NGNE’s MACD?
      NGNE’s MACD is -1.59, which suggests NGNE is a Buy.
        What is NGNE’s 5-day moving average?
        NGNE’s 5-day moving average is 21.60, which suggests NGNE is a Sell.
          What is NGNE’s 20-day moving average?
          NGNE 20-day moving average is 28.09, which suggests NGNE is a Sell.
            What is NGNE’s 50-day moving average?
            NGNE’s 50-day moving average is 25.43, which suggests NGNE is a Sell.
              What is NGNE’s 200-day moving average?
              NGNE’s 200-day moving average is 19.62, which suggests NGNE is a Buy.
                What is NGNE’s Williams % R (14)?
                NGNE’s Williams % R (14) is -94.62, which suggests NGNE is a Buy.
                  What is NGNE’s CCI (14)?
                  NGNE’s CCI (14) is -141.89, which suggests NGNE is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis